"The Antibody Trilogy"
11 Apr 2006
Problems with humanization, folding, expression levels, immunogenicity and cost continue to plague the field. Don't miss this opportunity to attend a Trilogy of meetings devoted to the expression of difficult proteins, including: 2 full days of problem solving for "finicky" proteins (Difficult to Express Proteins), 2 full days devoted specifically to expressing and engineering Recombinant Antibodies and a full day devoted to Monoclonal Antibodies. Besides an excellent array of scientific presentations, you will have numerous opportunities to network with other researchers working on similar issues.
SESSIONS & PRESENTATIONS
BASIC SCIENCE FOR "FINICKY" PROTEINS
- Process Conditions which Control Solubility and Proteolysis
- Impact of Native State Stability on Protein Secretion Levels
- Synthetic Peptide Scaffolds for Improving Bioproduction Microenvironments
- Solution by Fusion: A Parallel Approach to Address Problems with Proteins
- Effects of Truncation on Protein Expression and Crystallization
EXPRESSION, PURIFICATION AND CHARACTERIZATION SCIENCE AND STRATEGIES
- Split GFP and Its Application to Trapping Soluble Protein Domains
- Application of a System for Rapid Evaluation of Recombinant Protein Expression in Insect Cells
- High-Throughput Protein Production and Cell-Based Screening of a Comprehensive Secreted Protein Library
- Applications of the Wheat Germ Cell-Free Technology in Automated High-Throughput Production of Eukaryotic Proteins
CASE STUDIES
- Smart Solutions for the Overexpression of Soluble Mammalian Protein Targets
- Expression of Functional Peripheral Cannabinoid Receptor for Structural Studies
- Development of Filamentous Fungi as Industrially Relevant Gene Expression Hosts: Expression of the Thermophilic Enzyme Xylanase B (XynB) in Trichoderma reesei
- Exceptional Total and Functional Yields of the Human Adenosine (A2a) Receptor Expressed in the Yeast Saccharomyces Cerevisiae
- The Use of Cell-Free Systems to Produce Proteins for Functional and Structural Applications
- Pressure-Enhanced Protein Aggregate Refolding: Advantages in Comparison to Traditional Chaotrope-Based Methods
- Protecting and Stabilizing Proteins against Aggregation to Ease Their Processing and Production
NOVEL APPLICATION OF EXISTING PLATFORMS
- Baculovirus Expression of Two Taeniasis Diagnostic Antigens in Insect CellsAn Automated Micro-Fermenter Battery for Producing Recombinant Proteins
- An Improved S. cerevisiae System for Rapid and Inexpensive Production of Recombinant Proteins
- Information Rich Design of Expression Optimized Synthetic Genes
KEYNOTE PRESENTATION
Affinity Maturation of Antibodies: Insights from the Physiological Mechanism
ALTERNATIVE NATURAL IMMUNE RECEPTORS
- Structural and Functional Analysis of Hypervariable Immune Receptors in Insects
- Leucine-Rich Repeat (LRR) Modules: Linking Innate and Adaptive Immunity
- Comparative Studies of Immunoglobulins with an Emphasis on Single-Chain Antibodies in Sharks
- Nanobodies: The Smallest Intact Antigen-Binding Fragments Derived from Camel Heavy Chain Antibodies
- ANTICALINS: Small Antibody-Like Binding Proteins, Derived from the Lipocalin Scaffold, for Therapeutic Applications
STRATEGIES FOR IMPROVING ANTIBODY SELECTION, EFFICACY AND PRODUCTION
- Production of Recombinant Antibodies for Low-Abundance Proteins
- Cloned, Transgenic Livestock Produce Bispecific Antibodies for Immunotherapy of Melanoma
- Finding Rare and Unique Antibodies using Multiple Phage Display Libraries
- A Novel Non-Display Epitope Focused Library Method for Making 'Humaneered' Antibodies
- Rapid Custom Generation of Recombinant Antibodies
APPLICATIONS: Toxins, Biothreats and Emerging Diseases
- KEYNOTE ADDRESS - The Botulinum Antitoxin Story
- Passive Immunotherapy in an Outbreak Setting. A Case of SARS Antibodies.
- Human mABs for the Prophylaxis of West Nile Virus Infection
- Antibody-Based Therapeutics for HIV-1, Emerging and Biodefense-Related Viruses and IGF-Dependent Cancer
ASSAYS AND MONITORING
- Monitoring Product Quality as an Integral Part of Cell Line Development Process
- From DNA Array to Protein Array
- Mass Spectrometric Analysis of Intact Antibodies and Immunoconjugates
SELECTION, CHARACTERIZATION AND PRODUCTION
- High-Throughput Strategies for Monoclonal Antibody Selection and Production Cell Line Isolation
- Engineering Nanobodies for Therapy: Dealing with Bivalency, Bispecificity and Potency Optimization
- Increased Production of Humanized Monoclonal Antibodies in Chinese Hamster Ovary Cells
- Peptide Constructs for Immunization Against 'Impossible' Epitopes
- Rapid Cell Line Enrichment
ENHANCING EXPRESSION, SAFETY, AND EFFICACY
- Immunoassay Format Effects on Immunogenicity Assessment for Monoclonal Antibody Therapeutics Antibody Humanization by Framework Shuffling
- Measurement of the Functional Affinity Constant of a Monoclonal Antibody for Cell Surface Receptors
using Kinetic Exclusion Fluorescence Immunoassay
CASE STUDIES
- Isolation of Neutralizing Monoclonal Antibodies to Toxin A and Toxin B From Clostridium Difficile
- Tie-1 Targeted Inhibitor of Tumor Growth
Request InfoCompany website
Cambridge Healthtech Institute